The Medical Innovation Agenda for the 119th Congress
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Small Business
Learn more about our work for Small Businesses.
Accelerated access to novel cancer therapies at Moores Cancer Center
Learn how the EY Clinical Trial Fast Lane solution helps jumpstart clinical trials in 45 to 60 working days through rapid performance of functional services, deep understanding of clinical trial…
AdvaMed® Statement on House Passage of Critical R&D Tax Provision
AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker upon the passage of a research and development expensing tax provision critical to medtech innovation in the…
AdvaMed® Urges Congress to Pass R&D Tax Provision Promoting, Preserving Medtech Innovation
Scott Whitaker, president and CEO of AdvaMed, The Medtech Association®, today urged Congress to enact a research and development expensing tax provision critical to medtech innovation. The provision would delay…
AdvaMed® Calls on Congress to Reform Tax Code to Support Small Businesses
Following the introduction of the bipartisan American Innovation and Jobs Act in the U.S. Senate and its House companion the American Innovation and R&D Competitiveness Act, AdvaMed, The Medtech Association®,…
AdvaMed®’s Top 10 Medtech Wins in 2022
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel® companies, 2022 was a…
Future of Medtech: Define New Markets Before They Define You
This report from PwC presents three growth strategies to empower medtech companies to win in this competitive and rapidly changing environment.
AdvaMed® Champions Congressional Reauthorization of Vital Small Business Investment Programs
This week, the Senate and House unanimously approved the reauthorization of the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs for three years. Since early 2021, AdvaMed®…
New Episode of Medtech POV Podcast: Vibrato CEO Calls for Reauthorization of the Federal Small Business Innovation Funding Program
Juliana Elstad, President and CEO of Vibrato Medical, recently joined AdvaMed®’s Scott Whitaker on The Medtech POV podcast for a conversation on several policy initiatives.
Medical Technology Start-ups Get a Critical Boost Via “America’s Seed Fund”
The federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs support scientific development and product innovation benefiting patients in need and the public at large.